Stock ANGO ANGIODYNAMICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Company AngioDynamics, Inc.

Equities

ANGO

US03475V1017

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-18 pm EDT 		5-day change 1st Jan Change
6.12 USD -3.32% Intraday chart for AngioDynamics, Inc. -10.00% -21.94%
Apr. 08 North American Morning Briefing : Inflation Data, -2- DJ
Apr. 05 Oppenheimer Upgrades AngioDynamics to Outperform From Perform, $12 Price Target MT

Business Summary

AngioDynamics, Inc. is a transformative medical technology company. The Company is focused on restoring healthy blood flow in the body's vascular system, expanding cancer treatment options and improving quality of life for patients. It designs, manufactures, and sells a range of medical, surgical and diagnostic devices used by professional healthcare providers for vascular access, for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Its devices are generally used in minimally invasive, image-guided procedures. Its segments include Med Tech and Med Device. Its product categories include oncology, venous therapies, vascular interventions, and ports. Its oncology products include Model 1500X RF Generator, IsoLoc Endorectal Balloon, Habib 4X Laparoscopic Bipolar Resection Device, Habib 4X Bipolar Resection Device, and Alatus. Its venous therapies include VenaCure EVLT 1470 Pro Laser, VenaCure EVLT System, VenaCure EVLT Procedure Packs, and others.

Number of employees: 815

Sales per Business

USD in Million2022Weight2023Weight Delta
Med Device
71.5 %
- - 242 71.5 % -
Med Tech
28.5 %
- - 97 28.5 % -

Sales per region

USD in Million2022Weight2023Weight Delta
United States
83.5 %
266 84.1 % 283 83.5 % +6.30%
International
16.5 %
50 15.9 % 56 16.5 % +11.51%

Managers

Managers TitleAgeSince
James Clemmer CEO
 Chief Executive Officer 60 16-03-31
Stephen Trowbridge DFI
 Director of Finance/CFO 49 08-05-31
Juan Serna CTO
 Chief Tech/Sci/R&D Officer - 16-12-31
Kim Seabury CTO
 Chief Tech/Sci/R&D Officer 57 11-08-31
Scott Centea PRN
 Corporate Officer/Principal - -
Laura Piccinini PRN
 Corporate Officer/Principal 55 -
Marna Bronfen-Moore HRO
 Human Resources Officer 57 19-08-31
Chad Campbell PRN
 Corporate Officer/Principal - -
Benjamin Davis PRN
 Corporate Officer/Principal 59 15-02-28
Warren Nighan LAW
 General Counsel 55 17-03-31

Members of the board

Members of the board TitleAgeSince
Jan Reed BRD
 Director/Board Member 64 16-11-08
Howard Donnelly CHM
 Chairman 63 04-02-29
Wesley Johnson BRD
 Director/Board Member 65 07-01-28
Eileen Auen BRD
 Director/Board Member 61 16-11-08
James Clemmer CEO
 Chief Executive Officer 60 16-03-31
Michael Tarnoff BRD
 Director/Board Member 55 19-10-14
Karen Licitra BRD
 Director/Board Member 64 19-07-16
Lorinda Burgess BRD
 Director/Board Member 61 23-07-18

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 40,424,533 38,053,036 ( 94.13 %) 370,000 ( 0.9153 %) 94.13 %

Shareholders

NameEquities%Valuation
BlackRock Advisors LLC
11.82 %
4,712,616 11.82 % 28 M $
Vanguard Fiduciary Trust Co.
5.692 %
2,268,461 5.692 % 13 M $
Systematic Financial Management LP
4.848 %
1,932,154 4.848 % 11 M $
Morgan Stanley Investment Management, Inc.
4.733 %
1,886,200 4.733 % 11 M $
Millennium Management LLC
4.606 %
1,835,777 4.606 % 11 M $
Dimensional Fund Advisors LP
3.736 %
1,489,108 3.736 % 9 M $
Assenagon Asset Management SA
2.645 %
1,054,022 2.645 % 6 M $
Citadel Securities GP LLC
2.544 %
1,013,776 2.544 % 6 M $
STATE STREET CORPORATION
2.532 %
1,009,307 2.532 % 6 M $
Acadian Asset Management LLC
2.269 %
904,422 2.269 % 5 M $

Company contact information

AngioDynamics, Inc.

14 Plaza Drive

12110, Latham

+518 795 1400

http://www.angiodynamics.com
address AngioDynamics, Inc.(ANGO)

Sector

Healthcare
Healthcare Services
Healthcare Equipment & Supplies
Medical Equipment, Supplies & Distribution
Other Medical Equipment, Supplies & Distribution

Sales per Business

Sales per region

Ratings for AngioDynamics, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
6.12 USD
Average target price
13.5 USD
Spread / Average Target
+120.59%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

1st Jan change Capi.
ANGIODYNAMICS, INC. Stock AngioDynamics, Inc.
-21.94% 245M
ABBOTT LABORATORIES Stock Abbott Laboratories
-4.36% 183B
MEDTRONIC PLC Stock Medtronic plc
-3.87% 105B
BECTON, DICKINSON AND COMPANY Stock Becton, Dickinson and Company
-4.38% 67.36B
DEXCOM, INC. Stock DexCom, Inc.
+8.23% 51.77B
CENCORA, INC. Stock Cencora, Inc.
+15.54% 47.29B
HOYA CORPORATION Stock Hoya Corporation
-1.73% 40.2B
WEST PHARMACEUTICAL SERVICES, INC. Stock West Pharmaceutical Services, Inc.
+7.16% 27.62B
SARTORIUS STEDIM BIOTECH Stock Sartorius Stedim Biotech
-12.48% 21.75B
METTLER-TOLEDO INTERNATIONAL, INC. Stock Mettler-Toledo International, Inc.
-1.68% 25.51B
Other Medical Equipment, Supplies & Distribution
  1. Stock Market
  2. Equities
  3. ANGO Stock
  4. Company AngioDynamics, Inc.